Raras
Buscar doenças, sintomas, genes...
Leucodistrofia hipomielinizante autossômica recessiva VPS11-relacionada
ORPHA:466934CID-10 · G93.8OMIM 616683DOENÇA RARA

Qualquer leucodistrofia em que a causa da doença seja uma mutação no gene VPS11.

Mantido por Agente Raras·Colaborar como especialista →

Introdução

O que você precisa saber de cara

📋

Qualquer leucodistrofia em que a causa da doença seja uma mutação no gene VPS11.

Escala de raridade

CLASSIFICAÇÃO ORPHANET · BRASIL 2024
<1 / 1 000 000
Ultra-rara
<1/50k
Muito rara
1/20k
Rara
1/10k
Pouco freq.
1/5k
Incomum
1/2k
Prevalência
0.0
Worldwide
Casos conhecidos
13
pacientes catalogados
Início
Infancy
🏥
SUS: Cobertura mínimaScore: 15%
CID-10: G93.8
🇧🇷Dados SUS / DATASUS
PROCEDIMENTOS SIGTAP (2)
0202010694
Sequenciamento completo do exoma (WES)genetic_test
0301070040
Atendimento em reabilitação — doenças rarasrehabilitation
Você se identifica com essa condição?
O Raras está aqui pra te apoiar — com ou sem diagnóstico

Encontrou um erro ou informação desatualizada? Sugira uma correção →

Entender a doença

Do básico ao detalhe, leia no seu ritmo

Preparando trilha educativa...

Sinais e sintomas

O que aparece no corpo e com que frequência cada sintoma acontece

Partes do corpo afetadas

🧠
Neurológico
16 sintomas
❤️
Coração
2 sintomas
💪
Músculos
2 sintomas
🫃
Digestivo
2 sintomas
👁️
Olhos
2 sintomas
👂
Ouvidos
2 sintomas

+ 10 sintomas em outras categorias

Características mais comuns

100%prev.
Hipoplasia do corpo caloso
Frequente (79-30%)
100%prev.
Contratura em flexão
Frequência: 20/20
90%prev.
Deficiência intelectual
Muito frequente (99-80%)
90%prev.
Atraso global do desenvolvimento
Muito frequente (99-80%)
90%prev.
Convulsão
Muito frequente (99-80%)
90%prev.
Hipotonia
Muito frequente (99-80%)
38sintomas
Muito frequente (8)
Frequente (16)
Muito raro (3)
Sem dados (11)

Os sintomas variam de pessoa para pessoa. Abaixo estão as 38 características clínicas mais associadas, ordenadas por frequência.

Hipoplasia do corpo calosoHypoplasia of the corpus callosum
Frequente (79-30%)100%
Contratura em flexãoFlexion contracture
Frequência: 20/20100%
Deficiência intelectualIntellectual disability
Muito frequente (99-80%)90%
Atraso global do desenvolvimentoGlobal developmental delay
Muito frequente (99-80%)90%
ConvulsãoSeizure
Muito frequente (99-80%)90%

Linha do tempo da pesquisa

Publicações por ano — veja quando o interesse científico cresceu
Anos de pesquisa1desde 2026
Últimos 10 anos67publicações
Pico202511 papers
Linha do tempo
2026Hoje · 2026📈 2025Ano de pico
Publicações por ano (últimos 10 anos)

Encontrou um erro ou informação desatualizada? Sugira uma correção →

Genética e causas

O que está alterado no DNA e como passa nas famílias

Genes associados

1 gene identificado com associação a esta condição. Padrão de herança: Autosomal recessive.

VPS11Vacuolar protein sorting-associated protein 11 homologDisease-causing germline mutation(s) (loss of function) inTolerante
FUNÇÃO

Plays a role in vesicle-mediated protein trafficking to lysosomal compartments including the endocytic membrane transport and autophagic pathways. Believed to act as a core component of the putative HOPS and CORVET endosomal tethering complexes which are proposed to be involved in the Rab5-to-Rab7 endosome conversion probably implicating MON1A/B, and via binding SNAREs and SNARE complexes to mediate tethering and docking events during SNARE-mediated membrane fusion. The HOPS complex is proposed

LOCALIZAÇÃO

EndosomeLate endosome membraneLysosome membraneEarly endosomeCytoplasmic vesicleCytoplasmic vesicle, autophagosomeCytoplasmic vesicle, clathrin-coated vesicle

VIAS BIOLÓGICAS (1)
SARS-CoV-2 modulates autophagy
MECANISMO DE DOENÇA

Leukodystrophy, hypomyelinating, 12

An autosomal recessive neurologic disorder characterized by developmental delay, spasticity, truncal hypotonia, acquired microcephaly, intellectual disability with variable seizure disorder, accompanied by thin corpus callosum, paucity of white matter and delayed myelination.

EXPRESSÃO TECIDUAL(Ubíquo)
Útero
60.2 TPM
Cerebelo
59.7 TPM
Cervix Endocervix
59.0 TPM
Cérebro - Hemisfério cerebelar
58.2 TPM
Ovário
55.5 TPM
OUTRAS DOENÇAS (2)
hypomyelinating leukodystrophy 12dystonia 32
HGNC:14583UniProt:Q9H270

Variantes genéticas (ClinVar)

38 variantes patogênicas registradas no ClinVar.

🧬 VPS11: GRCh37/hg19 11q23.3-24.2(chr11:115887338-126148523)x3 ()
🧬 VPS11: NC_000011.9:g.(?_118007742)_(119170491_?)del ()
🧬 VPS11: GRCh37/hg19 11q23.3-25(chr11:116683755-134937416)x3 ()
🧬 VPS11: Single allele ()
🧬 VPS11: NM_021729.6(VPS11):c.1419C>G (p.Phe473Leu) ()
Ver todas no ClinVar

Vias biológicas (Reactome)

1 via biológica associada aos genes desta condição.

Diagnóstico

Os sinais que médicos procuram e os exames que confirmam

Carregando...

Tratamento e manejo

Remédios, cuidados de apoio e o que precisa acompanhar

Carregando informações de tratamento...

Onde tratar no SUS

Hospitais de referência no Brasil e o protocolo oficial do SUS (PCDT)

🇧🇷 Atendimento SUS — Leucodistrofia hipomielinizante autossômica recessiva VPS11-relacionada

🗺️

Selecione um estado ou use sua localização para ver resultados.

Dados de DATASUS/CNES, SBGM, ABNeuro e Ministério da Saúde. Sempre confirme a disponibilidade diretamente com o estabelecimento.

Pesquisa ativa

Ensaios clínicos abertos e novidades científicas recentes

Pesquisa e ensaios clínicos

Nenhum ensaio clínico registrado para esta condição.

🧪 Está conduzindo uma pesquisa?
Divulgue para pacientes e familiares que acompanham esta doença.
Divulgar pesquisa →

Publicações mais relevantes

Timeline de publicações
0 papers (10 anos)
#1

Adult-onset vanishing white matter disease caused by the EIF2B5 c.185A>T (p.Asp62Val) variant.

Frontiers in genetics2026

Vanishing white matter disease (VWMD; OMIM 603896), also known as childhood ataxia with central nervous system hypomyelination (CACH), is a rare autosomal recessive leukodystrophy caused by pathogenic variants in the EIF2B gene family (EIF2B1-EIF2B5). Clinical manifestations are highly heterogeneous, with onset ranging from fetal life to adulthood; adult-onset cases remain relatively rare and often present with atypical symptoms. Brain magnetic resonance imaging (MRI) and genetic testing are pivotal for diagnosis. We report a 32-year-old Chinese female with adult-onset VWMD characterized by intermittent headaches, progressive cognitive decline, menstrual irregularities, and hearing loss. Cranial MRI with diffusion-weighted imaging (DWI) revealed symmetrical periventricular and centrum semiovale white matter abnormalities. Whole-exome sequencing (WES) identified a homozygous missense variant in the EIF2B5 gene, formatted per Human Genome Variation Society (HGVS) guidelines as NM_001414.4:c.185A>T (p.Asp62Val). This variant was previously documented exclusively in a pediatric patient, representing the first report in an adult. Our case expands the phenotypic and age-related spectrum of EIF2B5-associated VWMD, highlighting that the c.185A>T variant is capable of manifesting in adulthood with non-classical features (e.g., headache as the initial symptom). Prior studies have confirmed that this variant impairs EIF2B complex function, which reinforces its pathogenic role in disrupting the integrated stress response (ISR) and maintaining white matter homeostasis. A literature review of 99 genetically confirmed adult-onset VWMD cases further underscores genotype-phenotype correlations: EIF2B5 is the most frequently mutated subunit in adult patients, with cerebellar ataxia, cognitive decline, and psychiatric symptoms as the predominant initial manifestations. Female patients often present with premature ovarian failure, a key diagnostic hallmark. Early genetic testing is crucial for definitive diagnosis, prenatal counseling, and symptomatic management. Notably, this study has limitations, including the lack of investigation into gene-gene interactions-factors that may modulate disease severity and phenotypic variability-and the unavailability of parental genetic data to fully validate zygosity.

#2

A novel splice site variant in DEGS1 leads to aberrant splicing and loss of DEGS1 enzyme activity, a VUS resolved.

medRxiv : the preprint server for health sciences2025 Apr 11

Pathogenic DEGS1 variants have been reported in individuals with autosomal recessive hypomyelinating leukodystrophy 18 (HLD18; MIM# 618404). We sought to resolve a 5' +4/+5 splice site variant of uncertain significance found in three individuals with HLD features. We used next-generation DNA and transcriptome sequencing, cell-based splicing assays, and tandem mass spectrometry to detect and characterize the splice site variant. We then performed RNA structure probing and conventional antisense oligonucleotide screening to investigate molecular mechanisms for potential therapeutic intervention. A homozygous, DEGS1 5' splice site variant, c.825+4_825+5delAGinsTT (NM_003676.4) was identified in all three participants. Although the gene has been associated with autosomal recessive hypomyelinating leukodystrophy, the variant has not been previously reported in any available databases or literature. We show that the splice site variant: 1) was sufficient to induce exon two skipping in most detected transcripts; 2) resulted in structural changes to the 5' and 3' splice site regions using RNA structure probing; and 3) corresponds to plasma sphingolipid profiles consistent with loss of sphingolipid delta(4)-desaturase activity. Our RNA and lipidomic evidence proved that the DEGS1 variant c.825+4_825+5delAGinsTT is pathogenic and suggested a mechanistic model to explain how exon two skipping is induced.

#3

Neuropsychological profile of POLR3A-related spastic ataxia.

Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology2025 Mar

POLR3-related disorders are a group of autosomal recessive neurodegenerative diseases that usually cause leukodystrophy and can lead to cognitive dysfunction. Literature reporting comprehensive neuropsychological assessment in POLR3A-related diseases is sparse. Here we describe the neuropsychological profile of a case of childhood-onset POLR3A-related spastic ataxia without leukodystrophy. Extensive neuropsychological assessment covering the domains of attention, executive function, memory, language, visuospatial processing and social cognition in a patient with a compound heterozygous POLR3Amutation (c.2000T>A (p.Leu667*) / c.1909+22G>A) and a spastic ataxic phenotype. Neuropsychological testing showed a marked slowing of basic information processing (reading, colour naming on Stroop test), executive deficits (alternating attention through Letter-Digit Substitution Test and semantic word fluency) and social cognition impairment (facial emotion recognition via Facial Expressive Action Stimulus Test, intention and emotion attribution via Story-based Empathy Task). While originally described as a typical hypomyelination disorder, leukodystrophy nor striatal lesions seem pivotal to cognitive dysfunction in POLR3-related disease, as demonstrated in this patient. Further investigation of a larger cohort of (c.1909 + 22G>A) heterozygous patients is warranted to reveal which neuropsychological features correspond to this less aggressive phenotype.

#4

Hypomyelination With Congenital Cataract: A Rare Genetic Leukodystrophy.

Cureus2025 Sep

Hypomyelination and congenital cataract (HCC) is a rare autosomal recessive disorder characterized by a triad of bilateral cataracts, neurological impairment, and diffuse cerebral hypomyelination. We report a case of a child, born of a consanguineous marriage, who presented with tremors and delayed motor abilities. Clinical examination revealed bilateral lamellar cataracts and microcephaly. MRI brain demonstrated diffuse white matter hypomyelination. The patient underwent cataract surgery with intraocular lens implantation and was managed with supportive rehabilitation. This case highlights the importance of early recognition of ophthalmic manifestations of systemic neurogenetic disorders, the diagnostic role of neuroimaging and genetic testing, and the necessity of multidisciplinary management.

#5

POLR3B-Related Hypomyelinating Leukodystrophy Type 8 (4H Syndrome): A Case Series of Two Siblings.

Cureus2025 Aug

We present a case series of two siblings from a consanguineous family with genetically confirmed POLR3B-related hypomyelinating leukodystrophy type 8 (4H syndrome), a rare autosomal recessive disorder characterized by hypomyelination, hypodontia, and hypogonadotropic hypogonadism. Despite sharing the same homozygous mutation, the siblings exhibited distinct clinical phenotypes, with the older child presenting with severe motor dysfunction, optic disc pallor, and requiring orthopedic surgery, while the younger maintained independent ambulation with milder neurological symptoms. Both exhibited high myopia and developmental delay, highlighting the multisystem nature of the disease.

Publicações recentes

Ver todas no PubMed

📚 EuropePMCmostrando 67

2026

Adult-onset vanishing white matter disease caused by the EIF2B5 c.185A>T (p.Asp62Val) variant.

Frontiers in genetics
2025

Hypomyelination With Congenital Cataract: A Rare Genetic Leukodystrophy.

Cureus
2025

POLR3B-Related Hypomyelinating Leukodystrophy Type 8 (4H Syndrome): A Case Series of Two Siblings.

Cureus
2025

SHQ1-related hypomyelinating leukodystrophy: A case report with imaging features and a homozygous variant.

Radiology case reports
2025

Cochlear implantation in Childhood Ataxia with Central nervous system Hypomyelination Syndrome.

Indian journal of otolaryngology and head and neck surgery : official publication of the Association of Otolaryngologists of India
2025

Biallelic ELOVL1 Variants Are Linked to Hypomyelinating Leukodystrophy, Movement Disorder, and Ichthyosis.

Movement disorders : official journal of the Movement Disorder Society
2025

Deletion Testing of the DEGS1 Gene Should Be Part of the Diagnostic Pipeline for Hypomyelinating Leukodystrophy (HLD18).

Human mutation
2025

A novel splice site variant in DEGS1 leads to aberrant splicing and loss of DEGS1 enzyme activity, a VUS resolved.

medRxiv : the preprint server for health sciences
2025

Bi-allelic variants in BRF2 are associated with perinatal death and craniofacial anomalies.

Genome medicine
2025

Neuropsychological profile of POLR3A-related spastic ataxia.

Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology
2025

First description of novel compound heterozygous mutations in HYCC1: clinical evaluations and molecular analysis in patient with hypomyelinating leukodystrophy-5 with retrospective view.

Journal of human genetics
2025

Assessment the Efficacy of the CRISPR System for Inducing Mutations in the AIMP2 Gene to Create a Cell Line Model of HLD17 Disease.

Molecular biotechnology
2024

Inherited white matter disorders: Hypomyelination (myelin disorders).

Handbook of clinical neurology
2024

Developmental Delay, Hypomyelination, and Nystagmus: Case and Approach.

Neuro-ophthalmology (Aeolus Press)
2024

A novel missense variant in HIKESHI: Clinical phenotype, in vitro functional testing, and potential for gene therapy.

American journal of medical genetics. Part A
2024

Homozygous EPRS1 missense variant causing hypomyelinating leukodystrophy-15 alters variant-distal mRNA m6A site accessibility.

Nature communications
2024

In silico characterization and identification of compound heterozygous variants in H/ACA Ribonucleoprotein Assembly Factor (SHQ1) from Indian population.

Journal of family medicine and primary care
2024

4-aminopyridine improves evoked potentials and ambulation in the taiep rat: A model of hypomyelination with atrophy of basal ganglia and cerebellum.

PloS one
2024

Case report: Neuropsychological assessment in a patient with 4H leukodystrophy.

The Clinical neuropsychologist
2023

A Chinese patient with POLR3A-related leukodystrophy: a case report and literature review.

Frontiers in neurology
2023

Hypomyelination caused by a novel homozygous pathogenic variant in FOLR1: complete clinical and radiological recovery with oral folinic acid therapy and review of the literature.

Orphanet journal of rare diseases
2023

Adult-Onset White Matter Vanishing Disease With Ovarian Failure in a Salvadoran Patient.

Cureus
2023

Craniofacial features of POLR3-related leukodystrophy caused by biallelic variants in POLR3A, POLR3B and POLR1C.

Journal of medical genetics
2022

Hypomyelinating Leukodystrophy 10 (HLD10)-Associated Mutations of PYCR2 Form Large Size Mitochondria, Inhibiting Oligodendroglial Cell Morphological Differentiation.

Neurology international
2022

A rare case of hypomyelinating leukodystrophy-14 benefiting from ketogenic diet therapy.

The Turkish journal of pediatrics
2022

A novel mutation in GJC2 associated with hypomyelinating leukodystrophy type 2 disorder.

Genomics &amp; informatics
2022

A novel variant of the POLR3A gene in a patient with hypomyelinating POLR3-related leukodystrophy.

Clinica chimica acta; international journal of clinical chemistry
2022

The First Korean Siblings With Adult-Onset 4H Leukodystrophy Related to Nonsynonymous POLR3B Mutations.

Neurology. Genetics
2022

Hypomyelinating Leukodystrophy 8 (HLD8)-Associated Mutation of POLR3B Leads to Defective Oligodendroglial Morphological Differentiation Whose Effect Is Reversed by Ibuprofen.

Neurology international
2021

Hypomyelinating Leukodystrophy 7 (HLD7)-Associated Mutation of POLR3A Is Related to Defective Oligodendroglial Cell Differentiation, Which Is Ameliorated by Ibuprofen.

Neurology international
2021

Pelizaeus-Merzbacher-Like Disease 1 Caused by a Novel Mutation in GJC2 Gene: A Case Report.

Iranian journal of medical sciences
2022

Knockdown of Golgi Stress-Responsive Caspase-2 Ameliorates HLD17-Associated AIMP2 Mutant-Mediated Inhibition of Oligodendroglial Cell Morphological Differentiation.

Neurochemical research
2021

Hypomyelination and Congenital Cataract: Clinical, Imaging, and Genetic Findings in Three Tunisian Families and Literature Review.

Neuropediatrics
2021

Expanding the genotypic spectrum of PYCR2 and a common ancestry in Thai patients with hypomyelinating leukodystrophy 10.

American journal of medical genetics. Part A
2021

Progress in elucidating pathophysiology of mucolipidosis IV.

Neuroscience letters
2021

Hypomyelinating Leukodystrophy 15 (HLD15)-Associated Mutation of EPRS1 Leads to Its Polymeric Aggregation in Rab7-Positive Vesicle Structures, Inhibiting Oligodendroglial Cell Morphological Differentiation.

Polymers
2021

A hypomyelinating leukodystrophy in German Shepherd dogs.

Journal of veterinary internal medicine
2021

Novel Mutations in NPC1 are Associated with Pelizaeus-Merzbacher-Like Disease: A Case Report.

International journal of general medicine
2021

Case Report: Severe Osteoporosis and Preventive Therapy in RNA Polymerase III-Related Leukodystrophy.

Frontiers in neurology
2021

Endocrine and Growth Abnormalities in 4H Leukodystrophy Caused by Variants in POLR3A, POLR3B, and POLR1C.

The Journal of clinical endocrinology and metabolism
2020

A recurrent de novo HSPD1 variant is associated with hypomyelinating leukodystrophy.

Cold Spring Harbor molecular case studies
2020

Identification of a deep intronic POLR3A variant causing inclusion of a pseudoexon derived from an Alu element in Pol III-related leukodystrophy.

Journal of human genetics
2020

4H leukodystrophy caused by a homozygous POLR3B mutation: Further delineation of the phenotype.

American journal of medical genetics. Part A
2020

PP1C and PP2A are p70S6K Phosphatases Whose Inhibition Ameliorates HLD12-Associated Inhibition of Oligodendroglial Cell Morphological Differentiation.

Biomedicines
2020

Expanding the clinical and neuroimaging features of NKX6-2-related hereditary spastic ataxia type 8.

European journal of medical genetics
2020

Recessive Ataxia Differential Diagnosis Algorithm (RADIAL) Versus Specific Niemann-Pick Type C Suspicion Indices: A Retrospective Algorithm Comparison.

Cerebellum (London, England)
2020

An update on clinical, pathological, diagnostic, and therapeutic perspectives of childhood leukodystrophies.

Expert review of neurotherapeutics
2019

Compound heterozygous mutations in SNAP29 is associated with Pelizaeus-Merzbacher-like disorder (PMLD).

Human genetics
2019

Hypomyelinating leukodystrophy-associated mutation of RARS leads it to the lysosome, inhibiting oligodendroglial morphological differentiation.

Biochemistry and biophysics reports
2020

Genetic and phenotypic characterization of NKX6-2-related spastic ataxia and hypomyelination.

European journal of neurology
2019

Novel POLR1C mutation in RNA polymerase III-related leukodystrophy with severe myoclonus and dystonia.

Molecular genetics &amp; genomic medicine
2019

A study in a Polish ataxia cohort indicates genetic heterogeneity and points to MTCL1 as a novel candidate gene.

Clinical genetics
2018

Bi-allelic POLR3A Loss-of-Function Variants Cause Autosomal-Recessive Wiedemann-Rautenstrauch Syndrome.

American journal of human genetics
2018

A novel homozygous mutation in POLR3A gene causing 4H syndrome: a case report.

BMC pediatrics
2018

Expanding the clinical and genetic spectra of NKX6-2-related disorder.

Clinical genetics
2017

Cerebellar hypoplasia with endosteal sclerosis is a POLR3-related disorder.

European journal of human genetics : EJHG
2017

Mutations in NKX6-2 Cause Progressive Spastic Ataxia and Hypomyelination.

American journal of human genetics
2017

4H Leukodystrophy: A Brain Magnetic Resonance Imaging Scoring System.

Neuropediatrics
2017

Hypomorphic mutations in POLR3A are a frequent cause of sporadic and recessive spastic ataxia.

Brain : a journal of neurology
2017

Gene therapy targeting oligodendrocytes provides therapeutic benefit in a leukodystrophy model.

Brain : a journal of neurology
2017

Severe leukoencephalopathy with cortical involvement and peripheral neuropathy due to FOLR1 deficiency.

Brain &amp; development
2016

Neonatal progeriod syndrome associated with biallelic truncating variants in POLR3A.

American journal of medical genetics. Part A
2016

Hypomyelinating Leukodystrophy due to HSPD1 Mutations: A New Patient.

Neuropediatrics
2016

PYCR2 Mutations cause a lethal syndrome of microcephaly and failure to thrive.

Annals of neurology
2015

Endocrine Aspects of 4H Leukodystrophy: A Case Report and Review of the Literature.

Case reports in endocrinology
2015

Exome sequencing reveals a novel WDR45 frameshift mutation and inherited POLR3A heterozygous variants in a female with a complex phenotype and mixed brain MRI findings.

European journal of medical genetics
2015

BRF1 mutations alter RNA polymerase III-dependent transcription and cause neurodevelopmental anomalies.

Genome research

Associações

Organizações que acompanham esta doença — pra ter apoio e orientação

Ainda não temos associações cadastradas para Leucodistrofia hipomielinizante autossômica recessiva VPS11-relacionada.

É de uma associação que acompanha esta doença? Fale com a gente →

Comunidades

Grupos ativos de quem convive com esta doença aqui no Raras

Ainda não existe comunidade no Raras para Leucodistrofia hipomielinizante autossômica recessiva VPS11-relacionada

Pacientes, familiares e cuidadores se organizam em comunidades pra compartilhar experiências, fazer perguntas e se apoiar. Você pode ser o primeiro.

Tire suas dúvidas

Perguntas, dicas e experiências compartilhadas aqui na página

Participe da discussão

Faça login para postar dúvidas, compartilhar experiências e interagir com especialistas.

Fazer login

Doenças relacionadas

Doenças com sintomas parecidos — ajudam quem ainda está buscando diagnóstico

Ordenadas pelo número de sintomas em comum.

Referências e fontes

Bases de dados externas citadas neste artigo

Publicações científicas

Artigos indexados no PubMed ligados a esta doença no grafo RarasNet — título, periódico e PMID direto da fonte, sem intermediação de IA.

  1. Adult-onset vanishing white matter disease caused by the EIF2B5 c.185A&gt;T (p.Asp62Val) variant.
    Frontiers in genetics· 2026· PMID 41700296mais citado
  2. A novel splice site variant in DEGS1 leads to aberrant splicing and loss of DEGS1 enzyme activity, a VUS resolved.
    medRxiv : the preprint server for health sciences· 2025· PMID 40297416mais citado
  3. Neuropsychological profile of POLR3A-related spastic ataxia.
    Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology· 2025· PMID 39739274mais citado
  4. Hypomyelination With Congenital Cataract: A Rare Genetic Leukodystrophy.
    Cureus· 2025· PMID 41111653mais citado
  5. POLR3B-Related Hypomyelinating Leukodystrophy Type 8 (4H Syndrome): A Case Series of Two Siblings.
    Cureus· 2025· PMID 40978896mais citado
  6. De novo variants in KDM2A cause a syndromic neurodevelopmental disorder.
    Am J Hum Genet· 2026· PMID 41468891recente
  7. Movement disorder phenotype in CTNNB1-syndrome: A complex but recognizable phenomenology.
    Parkinsonism Relat Disord· 2024· PMID 39067319recente
  8. Further delineation of Wiedemann-Rautenstrauch syndrome linked with POLR3A.
    Mol Genet Genomic Med· 2024· PMID 38348603recente
  9. Mucopolysaccharidosis-Plus Syndrome, a Rapidly Progressive Disease: Favorable Impact of a Very Prolonged Steroid Treatment on the Clinical Course in a Child.
    Genes (Basel)· 2022· PMID 35327996recente
  10. Cerebral folate transporter deficiency syndrome in three siblings: Why genetic testing for developmental and epileptic encephalopathies should be performed early and include the FOLR1 gene.
    Am J Med Genet A· 2021· PMID 34008900recente

Bases de dados e fontes oficiais

Identificadores e referências canônicas usadas para montar este verbete.

  1. ORPHA:466934(Orphanet)
  2. OMIM OMIM:616683(OMIM)
  3. MONDO:0014732(MONDO)
  4. GARD:17837(GARD (NIH))
  5. Variantes catalogadas(ClinVar)
  6. Busca completa no PubMed(PubMed)
  7. Q28065601(Wikidata)

Dados compilados pelo RarasNet a partir de fontes abertas (Orphanet, OMIM, MONDO, PubMed/EuropePMC, ClinicalTrials.gov, DATASUS, PCDT/MS). Este conteúdo é informativo e não substitui avaliação médica.

Conteúdo mantido por Agente Raras · Médicos e pesquisadores podem colaborar

Compêndio · Raras BR

Leucodistrofia hipomielinizante autossômica recessiva VPS11-relacionada

ORPHA:466934 · MONDO:0014732
Prevalência
<1 / 1 000 000
Casos
13 casos conhecidos
Herança
Autosomal recessive
CID-10
G93.8 · Outros transtornos especificados do encéfalo
Início
Infancy
Prevalência
0.0 (Worldwide)
MedGen
UMLS
C4225247
Wikidata
DiscussaoAtiva

Nenhuma novidade ainda. O agente esta monitorando.

0membros
0novidades